Abida Parveen passes away during biopsy
PIMS Hospital
PIMS Hospital
(Web Desk): A routine lung biopsy at Islamabad’s PIMS Hospital turned fatal, with the family alleging a shocking medical error and regulators stepping in to investigate.

A woman has lost her life at the Pakistan Institute of Medical Sciences (PIMS) Hospital after an alleged medical blunder during a biopsy procedure, sparking outrage and an official investigation.

According to a formal complaint, Abida Parveen, a resident of Dadyal, was admitted to the Pulmonology Department at PIMS on December 9 for treatment of respiratory issues. After initial assessments, the Head of the Pulmonology Department, Dr. Muhammad Israr, decided that a lung biopsy was necessary to determine her condition.

The biopsy was performed on December 16 at PIMS Hospital. However, within hours of the procedure, Abida Parveen’s condition reportedly worsened, and she passed away shortly afterward, leaving her family devastated and searching for answers.

The situation took a disturbing turn when the family later received a report from a private laboratory. According to the report, the tissue extracted during the procedure was allegedly from the liver rather than the lungs, raising serious questions about how the biopsy was conducted.

Also Read: Pakistan Railways overhauled: Major reforms boost freight

The bereaved family has held Dr. Muhammad Israr, Dr. Haroon Ashraf, and other members of the hospital staff responsible for what they describe as gross negligence. They argue that a basic medical error cost Abida Parveen her life.

In response, the family has submitted a detailed complaint to the Islamabad Healthcare Regulatory Authority (IHRA), attaching hospital slips and laboratory reports from PIMS Hospital as evidence.

Also Read: New tourist facilities announced for Murree

Following the complaint, IHRA officials have confirmed that formal proceedings have been initiated. The investigation aims to determine whether medical negligence occurred and to fix responsibility, as the case intensifies public concern over patient safety in major government hospitals.